Filing Details
- Accession Number:
- 0001209191-19-038981
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-06-25 17:21:41
- Reporting Period:
- 2019-05-09
- Accepted Time:
- 2019-06-25 17:21:41
- Original Submission Date:
- 2019-05-13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1006028 | Pure Bioscience Inc. | PURE | Miscellaneous Chemical Products (2890) | 330530289 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1743729 | Ivan Chen | 1725 Gillespie Way El Cajon CA 92020 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-09 | 120,689 | $0.29 | 270,689 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 100,000 at a price of $0.35 per share. This amendment reflects an amendment to the price per share.
Billionaire Hedge Funds
